Teladoc Health (NYSE:TDOC) Stock Crosses Below 50-Day Moving Average – Here’s Why

Teladoc Health, Inc. (NYSE:TDOC) shares passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $7.69 and traded as low as $7.12. Teladoc Health shares last traded at $7.2250, with a volume of 1,743,986 shares.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on TDOC shares. Citigroup boosted their price target on shares of Teladoc Health from $9.50 to $10.50 and gave the stock a “neutral” rating in a research note on Tuesday, October 21st. Zacks Research downgraded Teladoc Health from a “strong-buy” rating to a “hold” rating in a report on Monday, November 10th. Barclays initiated coverage on Teladoc Health in a research report on Tuesday, December 9th. They issued an “equal weight” rating and a $8.50 price target on the stock. Evercore ISI lowered their price objective on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research report on Thursday, October 30th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Teladoc Health in a report on Monday. Five research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $9.60.

Teladoc Health Stock Performance

The firm has a 50 day moving average of $7.69 and a two-hundred day moving average of $7.80. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.70 and a quick ratio of 2.60. The stock has a market cap of $1.28 billion, a PE ratio of -5.64 and a beta of 2.04.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. The company had revenue of $626.44 million for the quarter, compared to analysts’ expectations of $625.66 million. During the same quarter last year, the company earned ($0.19) earnings per share. The firm’s revenue for the quarter was down 2.2% on a year-over-year basis. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. Research analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In other Teladoc Health news, CEO Charles Divita III sold 17,138 shares of the company’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $7.63, for a total value of $130,762.94. Following the completion of the transaction, the chief executive officer owned 201,036 shares in the company, valued at $1,533,904.68. This represents a 7.86% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Fernando M. Rodrigues sold 4,209 shares of Teladoc Health stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $7.48, for a total value of $31,483.32. The disclosure for this sale is available in the SEC filing. Insiders sold 33,288 shares of company stock valued at $251,684 in the last ninety days. 0.58% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Teladoc Health

A number of hedge funds and other institutional investors have recently made changes to their positions in TDOC. IFP Advisors Inc raised its stake in Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 3,210 shares during the last quarter. SVB Wealth LLC acquired a new position in shares of Teladoc Health in the first quarter valued at approximately $37,000. Aster Capital Management DIFC Ltd raised its stake in shares of Teladoc Health by 101.1% during the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock worth $37,000 after purchasing an additional 2,425 shares during the last quarter. Bayforest Capital Ltd acquired a new stake in shares of Teladoc Health during the third quarter worth $58,000. Finally, Caitong International Asset Management Co. Ltd grew its position in Teladoc Health by 8,192.0% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 8,292 shares of the health services provider’s stock valued at $72,000 after buying an additional 8,192 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.